You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 4, 2025

Drug Price Trends for NDC 52817-0364


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 52817-0364

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for the Drug NDC: 52817-0364

Introduction

The drug identified by the National Drug Code (NDC) 52817-0364 is Triamterene 50 MG Capsule. This analysis will delve into the current market trends, price dynamics, and future projections for this specific medication.

Current Market Pricing

As of December 18, 2024, the average pharmacy cost for Triamterene 50 MG Capsule with the NDC 52817-0364 is approximately $6.42 per unit[1].

Historical Price Trends

To understand the price dynamics, it is crucial to look at historical trends. Prescription drug prices, including those for Triamterene, often experience significant increases, particularly in January and July of each year. In 2022, for instance, the average price increase in January was nearly $150 per drug (a 10% increase), and in July, it was $250 (a 7.8% increase)[2].

Seasonal Price Increases

The pharmaceutical industry is known for its seasonal price adjustments. Most price increases occur in January and July, with January seeing the highest number of increases. This trend is consistent over the years, with 2022 showing over 3000 drugs experiencing a price increase in January alone[2].

Impact of Specialty Pharmaceuticals

The overall pharmaceutical market is heavily influenced by specialty medications, which include complex and high-cost treatments. While Triamterene is not a specialty drug, the broader market trends driven by specialty pharmaceuticals can affect pricing strategies. For example, Vizient projects a 3.8% drug price inflation in 2024, largely driven by the increasing utilization of specialty and weight loss drugs[3].

National Drug Code (NDC) and Its Significance

The NDC 52817-0364 is a unique identifier that breaks down into three segments: the labeler code, product code, and package code. This system ensures that each drug product is uniquely identified, facilitating tracking and pricing analysis[4].

Factors Influencing Price Changes

Several factors contribute to price changes in prescription drugs:

  • Inflation: General inflation rates can influence drug prices. For instance, the Consumer Price Index (CPI-U) increased by 8.5% between July 2021 and July 2022, which was reflected in some drug price increases[2].
  • Market Demand: Changes in demand, especially for drugs treating chronic or complex conditions, can drive price adjustments.
  • Regulatory Environment: FDA regulations and compliance requirements can impact pricing strategies.

Significant Price Increases

While not all price changes are significant, some drugs experience substantial price hikes. For Triamterene, any significant price change would be noted in the context of these broader trends. In 2022, 15-18% of price increases in January and July met the criteria for significant price changes (greater than 10% and $20, or greater than $500 per package)[2].

Future Price Projections

Given the current market trends:

  • General Inflation: With the CPI-U expected to continue influencing drug prices, a moderate increase in the price of Triamterene can be anticipated.
  • Specialty Drug Impact: Although Triamterene is not a specialty drug, the overall market pressure from specialty pharmaceuticals could lead to a slight increase in prices across the board.
  • Seasonal Adjustments: Expect price increases in January and July, consistent with historical trends.

Projected Price Increase

Based on the Vizient projection of a 3.8% overall drug price inflation, and considering the historical trends and factors influencing price changes, it is reasonable to project a moderate price increase for Triamterene 50 MG Capsule. A potential increase of around 3-5% in the next year could be expected, aligning with broader market trends.

Key Takeaways

  • Current Pricing: The average pharmacy cost for Triamterene 50 MG Capsule is approximately $6.42 per unit as of December 18, 2024.
  • Historical Trends: Price increases are common in January and July, with significant increases observed in these months.
  • Market Influences: Specialty pharmaceuticals and general inflation rates impact the broader pharmaceutical market.
  • Future Projections: A moderate price increase of around 3-5% is projected for Triamterene 50 MG Capsule in the next year.

FAQs

What is the current price of Triamterene 50 MG Capsule?

As of December 18, 2024, the average pharmacy cost for Triamterene 50 MG Capsule is approximately $6.42 per unit[1].

When do most prescription drug price increases occur?

Most prescription drug price increases occur in January and July of each year[2].

How do specialty pharmaceuticals affect the overall drug market?

Specialty pharmaceuticals drive a significant portion of the drug price inflation, with a projected 4.18% increase in specialty medication prices in 2024[3].

What is the significance of the National Drug Code (NDC)?

The NDC is a unique identifier that helps in tracking and pricing analysis of drug products. It consists of three segments: the labeler code, product code, and package code[4].

What factors contribute to significant price changes in prescription drugs?

Factors include general inflation, market demand, and regulatory environments. Significant price changes are often defined as increases greater than 10% and $20, or greater than $500 per package[2].

Sources

  1. DrugPatentWatch, "Pharmaceutical drug prices and trends for triamterene"
  2. ASPE, "Price Increases for Prescription Drugs, 2016-2022"
  3. Vizient Inc., "Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals"
  4. FDA, "National Drug Code Database Background Information"

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.